Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Edan

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2024
Microstructural Damage and Repair in the Spinal Cord of Patients With Early Multiple Sclerosis and Association With Disability at 5 YearsMalo Gaubert, Benoit Combès, Elise Bannier, et al.
Annals of Neurology|May 31, 2017
Sodium intake and multiple sclerosis activity and progression in BENEFITKathryn C Fitzgerald, Kassandra L Munger, Hans-Peter Hartung, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2023
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective studyGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
European Neurology|August 22, 2012
Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesionsDimitri Renard, Bruno Brochet, Sandra Vukusic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2024
Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohortGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
Neurodegenerative Disease Management|August 3, 2023
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS studyGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
Neurology|July 17, 2025
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and ProgressionMarianna Cortese, Xiaojing Peng, Gilles Edan, et al.
Multiple Sclerosis and Related Disorders|August 29, 2022
Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patientsLucile Lescot, Mathilde Lefort, Soizic Leguy, et al.
Journal of Neuroimmunology|October 25, 2003
Genetic analysis of multiple sclerosis in Europeans: French dataMehdi Alizadeh, Emmanuelle Génin, Marie-Claude Babron, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2015
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndromeAdil Maarouf, Jean-Christophe Ferré, Wafaa Zaaraoui, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2024
Microstructural Damage and Repair in the Spinal Cord of Patients With Early Multiple Sclerosis and Association With Disability at 5 YearsMalo Gaubert, Benoit Combès, Elise Bannier, et al.
Annals of Neurology|May 31, 2017
Sodium intake and multiple sclerosis activity and progression in BENEFITKathryn C Fitzgerald, Kassandra L Munger, Hans-Peter Hartung, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2023
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective studyGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
European Neurology|August 22, 2012
Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesionsDimitri Renard, Bruno Brochet, Sandra Vukusic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2024
Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohortGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
Neurodegenerative Disease Management|August 3, 2023
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS studyGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
Neurology|July 17, 2025
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and ProgressionMarianna Cortese, Xiaojing Peng, Gilles Edan, et al.
Multiple Sclerosis and Related Disorders|August 29, 2022
Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patientsLucile Lescot, Mathilde Lefort, Soizic Leguy, et al.
Journal of Neuroimmunology|October 25, 2003
Genetic analysis of multiple sclerosis in Europeans: French dataMehdi Alizadeh, Emmanuelle Génin, Marie-Claude Babron, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2015
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndromeAdil Maarouf, Jean-Christophe Ferré, Wafaa Zaaraoui, et al.
Pageof 15